Leishmaniasis control in the light of the COVID-19 pandemic in Africa

Uwishema, Olivier, Sapkota, Suhail, Wellington, Jack, Onyeaka, Chinyere Vivian Patrick and Onyeaka, Helen 2022. Leishmaniasis control in the light of the COVID-19 pandemic in Africa. Annals of Medicine and Surgery 80 , 104263. 10.1016/j.amsu.2022.104263

Preview

PDF - Published Version Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (785kB) | Preview

Abstract

Leishmaniasis is a parasitic disease, endemic to Africa, Asia, and South America due to inadequate access to medication and underreporting of leishmaniasis cases. Leishmaniasis has two forms: cutaneous and visceral. The fight against leishmaniasis has been greatly affected by the coronavirus disease 2019 (COVID-19) pandemic that impacted resource distribution and access to medication. Continuous effort in vaccine development and affordable therapeutics are necessary to eliminate leishmaniasis in low-income countries. Further research is necessary to determine molecular drug resistance markers in leishmaniasis patients. In this analysis, we focus on the effect of COVID-19 on leishmaniasis in Africa.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Additional Information:	License information from Publisher: LICENSE 1: URL: http://creativecommons.org/licenses/by-nc-nd/4.0/, Start Date: 2022-07-21
Publisher:	Elsevier
ISSN:	2049-0801
Date of First Compliant Deposit:	3 August 2022
Date of Acceptance:	20 July 2022
Last Modified:	10 Feb 2024 02:20
URI:	https://orca.cardiff.ac.uk/id/eprint/151677

Citation Data

Cited 1 time in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item